awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37461942-029DAD0D-3D2F-45B0-AD52-705D114739C2
Q37461942-029DAD0D-3D2F-45B0-AD52-705D114739C2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37461942-029DAD0D-3D2F-45B0-AD52-705D114739C2
Long-term efficacy and safety of bosutinib in patients with advanced leukemia following resistance/intolerance to imatinib and other tyrosine kinase inhibitors.
P2860
Q37461942-029DAD0D-3D2F-45B0-AD52-705D114739C2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37461942-029DAD0D-3D2F-45B0-AD52-705D114739C2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
210ae297f7a7514dfbbaf97a2aae5952e3f8c2fd
P2860
Prior treatment with the tyrosine kinase inhibitors dasatinib and nilotinib allows stem cell transplantation (SCT) in a less advanced disease phase and does not increase SCT Toxicity in patients with chronic myelogenous leukemia and philadelphia pos